Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 10, 2023 - Issue
Submit an article Journal homepage
218
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis

Cynthia De la Garza-Ramos1 Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, FL, USAORCID Iconhttps://orcid.org/0000-0002-6476-0397View further author information
ORCID Icon,
S Ali Montazeri1 Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, FL, USAView further author information
,
Kaitlyn R Musto1 Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, FL, USAView further author information
,
Melissa D Kapp1 Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, FL, USAView further author information
,
Andrew R Lewis1 Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, FL, USAView further author information
,
Gregory Frey1 Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, FL, USAView further author information
,
Ricardo Paz-Fumagalli1 Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, FL, USAView further author information
,
Sumera Ilyas2 Division of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, MN, USAView further author information
,
Denise M Harnois3 Department of Transplant, Mayo Clinic, Florida, FL, USAView further author information
,
Umair Majeed4 Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville, FL, USAView further author information
,
Tushar Patel3 Department of Transplant, Mayo Clinic, Florida, FL, USAORCID Iconhttps://orcid.org/0000-0001-7021-9532View further author information
ORCID Icon &
Beau Toskich1 Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, FL, USACorrespondence[email protected]
View further author information
 show all
Pages 987-996 | Received 25 Apr 2023, Accepted 01 Jun 2023, Published online: 23 Jun 2023

References

  • Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7(1):6. doi:10.1038/s41572-020-00240-3
  • Ogasawara S, Koroki K, Kanzaki H, et al. Changes in therapeutic options for hepatocellular carcinoma in Asia. Liver Int off J Int Assoc Study Liver. 2022;42(9):2055–2066. doi:10.1111/liv.15101
  • Haber PK, Puigvehí M, Castet F, et al. Evidence-based management of hepatocellular carcinoma: systematic review and meta-analysis of randomized controlled trials (2002–2020). Gastroenterology. 2021;161(3):879–898. doi:10.1053/j.gastro.2021.06.008
  • Casadei-Gardini A, Rimini M, Tada T, et al. Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population. Eur J Cancer. 2023;180:9–20. doi:10.1016/j.ejca.2022.11.017
  • Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update. J Hepatol. 2021. doi:10.1016/j.jhep.2021.11.018
  • Riaz A, Gates VL, Atassi B, et al. Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. Int J Radiat Oncol Biol Phys. 2011;79(1):163–171. doi:10.1016/j.ijrobp.2009.10.062
  • Salem R, Padia SA, Lam M, et al. Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging. 2019;46(8):1695–1704. doi:10.1007/s00259-019-04340-5
  • Lencioni R, Llovet J. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52–60. doi:10.1055/s-0030-1247132
  • Montazeri SA, De la Garza-Ramos C, Lewis AR, et al. Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors. Eur J Nucl Med Mol Imaging. 2022;49(11):3892–3897. doi:10.1007/s00259-022-05776-y
  • Cheng A-L, Qin S, Ikeda M, et al. Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol. 2022;76(4):862–873. doi:10.1016/j.jhep.2021.11.030
  • Pfister D, Núñez NG, Pinyol R, et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature. 2021;592(7854):450–456. doi:10.1038/s41586-021-03362-0
  • Lewandowski RJ, Gabr A, Abouchaleh N, et al. Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma. Radiology. 2018;287(3):1050–1058. doi:10.1148/radiol.2018171768
  • la Garza-Ramos C D, Montazeri SA, Croome KP, et al. Radiation segmentectomy for the treatment of solitary hepatocellular carcinoma: can outcomes be compared to surgical resection? J Vasc Interv Radiol. 2022. doi:10.1016/j.jvir.2022.03.021
  • Dhondt E, Lambert B, Hermie L, et al. (90)Y radioembolization versus drug-eluting bead chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE Phase II randomized controlled trial. Radiology. 2022:211806. doi:10.1148/radiol.211806
  • Sarwar A, Bonder A, Hassan L, et al. Factors associated with complete pathologic necrosis of hepatocellular carcinoma on explant evaluation after locoregional therapy: a national analysis using the UNOS database. AJR Am J Roentgenol. 2022. doi:10.2214/AJR.22.28385

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.